Title : Impact of POR*28 on the clinical pharmacokinetics of CYP3A phenotyping probes midazolam and erythromycin.

Pub. Date : 2013 Mar

PMID : 23324807






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Whereas midazolam is metabolized by both CYP3A4 and CYP3A5, erythromycin is exclusively oxidized by CYP3A4. Midazolam cytochrome P450 family 3 subfamily A member 5 Homo sapiens
2 RESULTS: In patients expressing CYP3A5, POR*28 carriers showed 45% lower midazolam metabolic ratios compared with POR*1/*1 patients (P<0.001). Midazolam cytochrome P450 family 3 subfamily A member 5 Homo sapiens
3 This is in line with a lower CYP3A5 activity toward midazolam for POR*28 carriers. Midazolam cytochrome P450 family 3 subfamily A member 5 Homo sapiens